Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT Meeting Abstract
| Authors: | Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K. N.; Van Tine, B. A.; Chugh, R.; Cranmer, L. D.; Gordon, E. M.; Hornick, J. L.; Kwiatkowski, D. J.; Du, H.; Grigorian, B.; Schmid, A. N.; Hou, S.; Harris, K.; Desai, N.; Dickson, M. A. |
| Abstract Title: | Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368300377 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.11516 |
| Notes: | Meeting Abstract: 11516 -- Source: Wos |
